2Krichevsky A.,Graessmann A.,Nissim A..Antibody fragments selectedby phage display against the nuclear localization signal of the HIV-1 Vpr protein inhibit nuclear import in permeabilized and intact cultured cells. Virology 2003,305(1):77-92.
3Andew J.T.,George F.J., Tai M.S.et al. Radio metal labeling of recombinant proteins by a genetically engineered minimal chelation site:Technetium:99m coordination by single chain Fv antibody fusion proteins through a C terminal cystein peptide. Proc Natl
4Deng Ning,Xiang Junjian et al. Expression, Purification and Characterization of Humanized Anti-HBs Fab Fragment, Journal of Biochemistry, 2003,134 (5): 330- 331.
5Reiter Y.,Brinkmann U.,Lee B.K.et al.Engineering antibody Fvfragments for cancer detection and therapy:Disulfide stabilized Fvfragment. Nature Biotechnol, 1996,14(10): 1239- 1245.
7Zebedee S L, Barbas C F, Hom Y L et al. Human combination antibody libraries to hepatitis B surface antigen. Proc Nalt Acad Sci USA ,1992, 89:3175～3179
8Sowyer L A. Antibodies for the prevention and treatment of virail disease. Antiviral Reasearch, 2000, 47: 57～77
9Sambrook J,Pritsch E F Maniais T. Molecular cloning: A laboratory manual, 2nded, New York: Cold Spring Harbor laboratory Press, 1989
10In-Hak Choi, Jun-Ho Chun, Ik-Jung Kim. Generation of human Fab monoclonal antibodies against PreS2 of Hepatitis B Virus using antibody phage display library. J Korean Soc Microbiol, 1999,34( 1 ):21～30
8Reiter Y,Pastan I. Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins. Clin Cancer Res, 1996,2(2) :245-252.
9Reiter Y, Brinkmann U, Lee B, et al. Engineering antibody Fv fragment for cancer detection and therapy:disulfide-stabilized Fv fragment. Nature Biotech, 1996,14(10) : 1239-1245.
10Colleluoria DM,Tiena D. Expression,purification,and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development Protein Expression and Purification,2005,39(2) :229-236.
